Ebselen

DB12610InvestigationalSmall molecule

Ebselen has been investigated for the treatment and basic science of Meniere's Disease, Type 2 Diabetes Mellitus, and Type 1 Diabetes Mellitus.

Chemical structure of Ebselen
Formula / weight
C13H9NOSe · 274.192 g/mol (avg)
Code names
DR-3305 · SPI-1005

Resolves to

Compound
UNII40X2P7DPGHCAS60940-34-3ChEMBLCHEMBL51085ChEBI77543PubChem3194
Structure
InChIKeyDYEFUKCXAQOFHX-UHFFFAOYSA-NSMILESO=C1N([Se]C2=CC=CC=C12)C1=CC=CC=C1
Targets
O75164KDM4AP02768ALBP34913EPHX2

What you can answer from here — as of January 29, 2025

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
896Drug interactionsStructured to mechanism, not free text
Sign in
15Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ebselen, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In